Publications

peptide inhibitor design, SARS-CoV-2, cyclic peptides, molecular dynamics Dana Matthews peptide inhibitor design, SARS-CoV-2, cyclic peptides, molecular dynamics Dana Matthews

Exploiting Hydrophobic Amino Acid Scanning to Develop Cyclic Peptide Inhibitors of the SARS-CoV-2 Main Protease with Antiviral Activity

Katriona Harrison, Patrick W. Carlos, Sven Ullrich, Anupriya Aggarwal, Jason Johansen‐Leete, Vishnu Mini Sasi, Isabel Barter, Joshua WC. Maxwell, Max J. Bedding, Mark Larance, Stuart Turville, Alexander Norman, Colin J. Jackson, Christoph Nitsche, and Richard J. Payne*

Exploiting Hydrophobic Amino Acid Scanning to Develop Cyclic Peptide Inhibitors of the SARS-CoV-2 Main Protease with Antiviral Activity

Chemistry – A European Journal, 2024

Read More
Cytochrome-P450, cyclic peptides Dana Matthews Cytochrome-P450, cyclic peptides Dana Matthews

An Engineered Biarylitide Cross-Linking P450 from RiPP Biosynthesis Generates Alternative Cyclic Peptides

Maxine Treisman, Laura Coe, Yongwei Zhao, Vishnu Mini Sasi, Jemma Gullick, Mathias H. Hansen, Aviva Ly, Victor Leichthammer, Caroline Hess, Daniel L. Machell, Ralf B. Schittenhelm, Joel Hooper, Colin J. Jackson, Julien Tailhades, James J. De Voss* and Max J. Cryle*

An Engineered Biarylitide Cross-Linking P450 from RiPP Biosynthesis Generates Alternative Cyclic Peptides

Organic Letters, 2024

Read More

A full list of publications can be found on Google Scholar: